IUPAC/Chemical Name
2,3-Dioxabicyclo(3.3.1)nonan-7-one, 4-(2-(2,4-bis(trifluoromethyl)phenyl)ethenyl)-4,8-dimethyl-(1S-(1alpha,4beta(Z),5alpha,8beta))-
InChi Key
LRTRTVPZZJAADL-DAHZFVMQSA-N
InChi Code
InChI=1S/C19H18F6O3/c1-10-15(26)8-13-9-16(10)27-28-17(13,2)6-5-11-3-4-12(18(20,21)22)7-14(11)19(23,24)25/h3-7,10,13,16H,8-9H2,1-2H3/b6-5-/t10-,13+,16+,17+/m1/s1
SMILES Code
O=C1C[C@]2([H])[C@](C)(/C=C\C3=CC=C(C(F)(F)F)C=C3C(F)(F)F)OO[C@](C2)([H])[C@@H]1C
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
408.34
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Maggs JL, Bishop LP, Batty KT, Dodd CC, Ilett KF, O'Neill PM, Edwards G, Kevin Park B. Hepatocellular bioactivation and cytotoxicity of the synthetic endoperoxide antimalarial arteflene. Chem Biol Interact. 2004 Mar 15;147(2):173-84. PubMed PMID: 15013819.
2: Cazelles J, Robert A, Meunier B. Characterization of the Main Radical and Products Resulting from a Reductive Activation of the Antimalarial Arteflene (Ro 42-1611). J Org Chem. 1999 Sep 3;64(18):6776-6781. PubMed PMID: 11674686.
3: Bishop LP, Maggs JL, O'Neill PM, Park BK. Metabolism of the antimalarial endoperoxide Ro 42-1611 (arteflene) in the rat: evidence for endoperoxide bioactivation. J Pharmacol Exp Ther. 1999 Apr;289(1):511-20. PubMed PMID: 10087044.
4: Radloff PD, Philipps J, Nkeyi M, Sturchler D, Mittelholzer ML, Kremsner PG. Arteflene compared with mefloquine for treating Plasmodium falciparum malaria in children. Am J Trop Med Hyg. 1996 Sep;55(3):259-62. PubMed PMID: 8842111.
5: Jakobsen PH, Staalsø T, Bendtzen K, Stürchler D. The antimalarial drug, Ro 42-1611 (arteflene), does not affect cytoadherence and cytokine-inducing properties of Plasmodium falciparum malaria parasites. Trop Med Parasitol. 1995 Jun;46(2):88-92. PubMed PMID: 8525291.
6: Somo-Moyou R, Mittelholzer ML, Sorenson F, Haller L, Stürchler D. Efficacy of Ro 42-1611 (arteflene) in the treatment of patients with mild malaria: a clinical trial in Cameroon. Trop Med Parasitol. 1994 Sep;45(3):288-91. PubMed PMID: 7899806.
7: Weidekamm E, Dumont E, Jaquet C. Tolerability and pharmacokinetics of Ro 42-1611 (arteflene) in man. Trop Med Parasitol. 1994 Sep;45(3):278-83. PubMed PMID: 7899804.
8: Girometta MA, Jauch R, Ponelle C, Guenzi A, Wiegand-Chou RC. Animal pharmacokinetics and metabolism of the new antimalarial Ro 42-1611 (arteflene). Trop Med Parasitol. 1994 Sep;45(3):272-7. PubMed PMID: 7899803.
9: Jaquet C, Stohler HR, Chollet J, Peters W. Antimalarial activity of the bicyclic peroxide Ro 42-1611 (arteflene) in experimental models. Trop Med Parasitol. 1994 Sep;45(3):266-71. PubMed PMID: 7899802.
